Macrophages and Lymphocytes pp 555-568 | Cite as
Tobacco Smoke and the Pulmonary Alveolar Macrophage
Abstract
The pulmonary alveolar macrophage (PAM) has been shown by numerous investigators to be responsible for maintaining sterility of the lower respiratory tract (4, 8). This key host defense cell must interact with and destroy invading microorganisms, as well as inactivate and remove various non-viable particulates to which the lung is exposed. Perhaps the most common particulate in this class is tobacco smoke, a complex chemical aerosol comprised of over 3,000 separate gaseous, liquid and solid components. The lung is the primary target organ affected by tobacco smoke and the first line of resistance to the inhaled smoking products is the alveolar macrophage. Failure on the part of this phagocyte to deal effectively with this environmental inhalant could conceivably lead to an increased susceptibility to microbial infection, as well as an altered pulmonary integrity. We have investigated, therefore, the effects of tobacco smoke on the structure, function, and metabolism of alveolar macrophages harvested by bronchopulmonary lavage from rats previously exposed to carefully quantified dosages of tobacco smoke for periods of 30–180 consecutive days.
Keywords
Tobacco Smoke Alveolar Macrophage Volume Density Smoke Exposure Oxygen MetabolismPreview
Unable to display preview. Download preview PDF.
References
- 1.Davies, P., Sornberger, G. C. and Huber, G. L. Amer. Rev. Resp. Dis. 116 (1977) 1113.Google Scholar
- 2.Davies, P., Sornberger, G. C. and Huber, G. L. Lab. Invest. 37 (1977) 297.PubMedGoogle Scholar
- 3.Drath, D. B. and Karnovsky, M. L. J. Exp. Med. 145 (1975) 257.Google Scholar
- 4.Green, G. M. Ann. Rev. Med. 19 (1968) 315.PubMedCrossRefGoogle Scholar
- 5.Green, G. M., Powell, G. M. and Moriss, T. G. J. Clin. Invest. 50 (1971) 40a.Google Scholar
- 6.Gross, P. and DeTreville, R. T. P. Arch. Environ. Hlth. 17 (1968) 720.Google Scholar
- 7.Harris, J. O., Swenson, E. W. and Johnson, J. E. J. Clin. Invest. 49 (1970) 2086.Google Scholar
- 8.Huber, G. L., Johanson, W. G. and LaForce, F. M. In: Lung biology in health and disease (Ed. C. Lenfant) Vol. 5, Marcel Dekker, Inc. New York (1977) 979.Google Scholar
- 9.Huber, G. L., Pochay, V. E., Mahajan, V. K., McCarthy, C. R. Hinds, W. C., Davies, P., Drath, D. B. and Sornberger, G. C. Bull. Eur. Physiopathol. Respir. 13 (1977) 145.PubMedGoogle Scholar
- 10.Karnovsky, M. L., Lazdins, J. and Simmons, S. In: Mononuclear phagocytes in immunity, infection and pathology (Ed. R. Van Furth ), Blackwell Scientific Publications, Oxford, England (1975) 423.Google Scholar
- 11.LaForce, F. M., Kelly, W. J. and Huber, G. L. Am. Rev. Resp. Dis. 108 (1973) 784.PubMedGoogle Scholar
- 12.MacKaness, G. B. J. Expt. Med. 120 (1964) 105.CrossRefGoogle Scholar
- 13.Matulionis, D. H. and Traurig, H. H. Lab. Invest. 37 (1977) 314.PubMedGoogle Scholar
- 14.Michell, R. H., Pancake, S. J., Moseworthy, J. and Karnovsky, M. L. J. Cell. Biol. (1969) 216.Google Scholar
- 15.Pratt, S. A., Smith, M. H., Ladman, A. J. and Finley, T. N. Lab. Invest. 24 (1971) 331.PubMedGoogle Scholar
- 16.Root, R. K., Metcalf, J., Oshino, M. and Chance, B. J. Clin. Invest. 55 (1974) 945.Google Scholar
- 17.Salin, M. L. and McCord, J. M. Clin. Invest. 56 (1975) 1319.Google Scholar
- 18.Sorokin, S. O. In: Lung biology in health and disease (Ed. C. Lenfant) Vol. 5, Marcel Dekker, Inc., New York (1977) 711.Google Scholar
- 19.Underwood, E. E. In: Quantitative stereology. Addison-Wesley, Reading, Massachusetts (1970) 119.Google Scholar
- 20.Vassar, P. S., Culling, C., Saunders, A. M. Arch. Pathol. 70 (1960) 649.PubMedGoogle Scholar
- 21.Warr, G. A. and Martin, R. R. J. Reticuloendo. Soc. 23 (1978) 53.Google Scholar